TheraRadar
Clinical-Stage Companies / Nihon Pharmaceutical

Nihon Pharmaceutical

Pre-Approval PRO BETA
⚫

Inactive Company

No clinical trial activity in 3+ years. This company may have been acquired, shut down, or pivoted away from clinical development. Last trial started: 8/26/2019

18
Total Trials
13
Phase 3
5
Phase 2
0
Recruiting
238
Score

Pipeline by Phase

Phase 3
13
Phase 2
5
Phase 1
1

Therapeutic Focus

Bowel Disease Bullous Pemphigoid Gastric Cancer Patients Who Receive Colonoscopy Patients Undergoing Gastrointestinal Endoscopy

Clinical Trials (18)

NCT03794310 Phase 3 COMPLETED

Study of NPF-08 in Patients Who Receive Colonoscopy

Started: 1/5/2019

NCT03263910 Phase 3 COMPLETED

Study of NPO-11 in Patients Undergoing Gastrointestinal Endoscopy

Started: 8/21/2017

NCT02221271 Phase 3 COMPLETED

Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome

Started: 10/1/2014

NCT02250391 Phase 3 COMPLETED

Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis

Started: 9/1/2014

NCT01827072 Phase 3 COMPLETED

Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Multifocal Motor Neuropathy.

Started: 4/1/2013

NCT01824251 Phase 3 COMPLETED

Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.

Started: 4/1/2013

NCT01696500 Phase 3 COMPLETED

Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

Started: 10/1/2012

NCT01408550 Phase 3 COMPLETED

Phase III Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids

Started: 8/1/2011

NCT01411189 Phase 3 COMPLETED

Phase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy

Started: 9/1/2011

NCT01411176 Phase 3 COMPLETED

Phase III Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy

Started: 9/1/2011

NCT00742599 Phase 3 COMPLETED

Phase III Controlled Clinical Study of NPO-11 in Patients Undergoing Gastric Endoscopy

Started: 9/1/2008

NCT00740324 Phase 3 COMPLETED

Exploratory Study of Additional Use of Scopolamine Butylbromide, Glucagon or NPO-11 Following Single Dose of NPO-11 in Healthy Adult Men

Started: 8/1/2008

NCT00745459 Phase 3 COMPLETED

Phase III General Clinical Study of NPO-11 in Patients Undergoing Gastric Endoscopy

Started: 9/1/2008

NCT02265939 Phase 2 COMPLETED

Phase Ⅱ Dose Response Study of NPO-13 in Patients Undergoing Total Colonoscopy

Started: 10/1/2014

NCT04097574 Phase 2 COMPLETED

Study of NPO-13 During Colonoscopy

Started: 8/26/2019

NCT01845584 Phase 2 COMPLETED

Phase II Clinical Trial of NPB-01 in Patients With Anti-aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder Not Provided Adequate Effect of Therapy to Steroids Plus Therapy.

Started: 5/1/2013

NCT00809822 Phase 2 COMPLETED

Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids.

Started: 11/1/2008

NCT03423771 Phase 1 COMPLETED

Phase I/II Clinical Trial of NPF-08 in Healthy Volunteers

Started: 10/6/2017

Drug Candidates

NPF-08 （1-day treatment） NPF-08 （2-day split dose） Moviprep（1-day treatment） NPO-13 NPO-13: l-menthol NPO-11 Placebo NPF-08 NPB-01 NPB-06
Activity Status: Inactive
Last Trial Started: 8/26/2019
Last Trial Ended: 3/26/2020
Trials (12 months): 0
Completed Trials: 18
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.